Mizuho Securities analyst Irina Koffler said Teva Pharma's (NYSE: TEVA) cost cuts exceeded expectations and they expected a positive reaction ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE